Welcome to LookChem.com Sign In|Join Free

CAS

  • or

49615-99-8

Post Buying Request

49615-99-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

49615-99-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 49615-99-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,9,6,1 and 5 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 49615-99:
(7*4)+(6*9)+(5*6)+(4*1)+(3*5)+(2*9)+(1*9)=158
158 % 10 = 8
So 49615-99-8 is a valid CAS Registry Number.

49615-99-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (2-cyanophenoxy)acetonitrile

1.2 Other means of identification

Product number -
Other names 2-cyanomethoxybenzonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:49615-99-8 SDS

49615-99-8Relevant articles and documents

A benzofuran-β-Alaninamide based "turn-on" fluorescent chemosensor for selective recognition of Fe3+ ions

Madhu,Sivakumar,Sribalan, Rajendran

, p. 14426 - 14434 (2019)

A benzofuran-β-Alaninamide based chemosensor, 3-(3-((4-methylbenzyl)amino)propanamido)benzofuran-2-carboxamide (BAA), was designed and synthesized for selective detection of Fe3+ ions. The binding ability of BAA towards Fe3+ in DMSO/

Benzothiophenes and benzofurans and antiallergic use thereof

-

, (2008/06/13)

Novel benzothiophene and benzofuran derivatives having antiallergic activity are described as well as a method of manufacture, pharmaceutical compositions, and methods of use therefor. The disclosure describes the use of derivatives for prevention of the release of mediators including histamine and leukotrienes from basophils and mast cells, and prevent respiratory burst in neutrophils providing activity useful in cardiovascular disorders as well as in antiinflammatory, psoriasis, and antimigraine treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 49615-99-8